bazedoxifene has been researched along with tolfenamic acid in 1 studies
| Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) | Studies (tolfenamic acid) | Trials (tolfenamic acid) | Recent Studies (post-2010) (tolfenamic acid) |
|---|---|---|---|---|---|
| 307 | 69 | 249 | 294 | 47 | 132 |
| Protein | Taxonomy | bazedoxifene (IC50) | tolfenamic acid (IC50) |
|---|---|---|---|
| phospholipase A2 precursor | Homo sapiens (human) | 7.74 | |
| cysteine protease ATG4B isoform a | Homo sapiens (human) | 8.17 | |
| Cytochrome c oxidase subunit 2 | Homo sapiens (human) | 1.29 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, T; Hosoya, K; Kadono, K; Moriguchi, H; Nakamori, F; Naritomi, Y; Teramura, T; Terashita, S; Tetsuka, K; Yamano, K | 1 |
1 other study(ies) available for bazedoxifene and tolfenamic acid
| Article | Year |
|---|---|
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
Topics: Administration, Oral; Biotransformation; Cell Membrane Permeability; Cytochrome P-450 Enzyme System; Glucuronides; Glucuronosyltransferase; Humans; Intestinal Absorption; Intestines; Isoenzymes; Kinetics; Metabolic Clearance Rate; Microsomes; Models, Biological; Pharmaceutical Preparations; Recombinant Proteins; Substrate Specificity | 2012 |